Pre-congress review courses
- Ultrasound Course
Plenary Sessions
Concurrent Sessions:
- Clinical
- Basic Science
- Highlighted Symposia
- Education Series

Pre-congress review courses

1. ACR Review Course for Clinicians
Date: 11 July
Fee: Free for full and day delegates
Seats are limited, pre-registration is required.

2. APLAR Basic Science Course
Date: 11 July
Fee: Free for full and day delegates
Seats are limited, pre-registration is required.

3. APLAR Musculoskeletal Ultrasound Course in Rheumatology
From basic to intermediate
Date: 9-11 July
Language of teaching: English
No. of delegates: Limited to 60 persons
(registered on a first come, first served basis)
Fees: HK$4,000/ US$500 (if registered before 30 April)
HK$4,600 / US$600 (if registered after 30 April)
Course Information
Registration Form

Content:
1. Overview & development of MSK USG
2.
 Artefacts and pitfalls in USG
3. Applications of MSK USG in Rheumatology
4. Training and skill acquistion in MSK USG
5. USG findings in normal joints
6. USG findings in common rheumatic diseases
¡E RA
¡E Spondyloarthritis
¡E Osteoarthritis (OA)
7. Hand-on sessions
¡E Normal subjects and patients with pathology
¡E Simple USG guided intervention training


Plenary Sessions

12 July
Rheumatoid Arthritis
¡E Overview of biological therapies in RA
¡E Is remission possible in RA?
¡E Pathogenesis of RA

13 July
Osteoporosis
¡E Osteoporosis: the scope of the problem in the Asian Pacific region
¡E Update on the treatment of osteoporotic fractures
¡E Genetic and environmental determinants of osteoporosis

14 July
Systemic Lupus Erythematosus
¡E Therapies of SLE: what have we achieved and what are our future targets?
¡E Update on B cell therapies in SLE
¡E Genetics in SLE

15 July
Ankylosing Spondylitis
¡E Immunopathogenesis of AS
¡E Classification criteria for AS: what is new?
¡E Update on the novel therapies of AS


Concurrent Sessions

Clinical
Rheumatoid Arthritis
¡E Special issues on the safety of TNF blockers:
          - Prevention of latent tuberculosis (TB) reactivation in areas of high TB burden
          - Prevention of hepatitis B flare
          - Malignancy and other adverse reactions - data from patient registry
¡E Biological therapies of RA: beyond TNF blockade
¡E Use of biological therapies in the Asian Pacific region
¡E Biology of IL-6 and its blockade in clinical practice

Systemic Lupus Erythematosus
¡E Basic mechanisms of atherosclerosis and the role of the immune system
¡E New avenues in the antiphospholipid antibody syndrome
¡E Cardiovascular morbidity of SLE: results of an international cohort
¡E Lupus nephritis forum
¡E Epidemiology and survival of SLE in Hong Kong
¡E Infection in SLE
¡E Cognitive impairment in SLE

Ankylosing Spondylitis
¡E Efficacy of NSAIDs in the prevention of structural progression in AS
¡E Sequential therapy of AS with anti-TNF and thalidomide
¡E Enthesitis related juvenile idiopathic arthritis

Vasculitis
¡E Update on the management of Behcet's disease
¡E Update on the diagnosis and management of large vessel vasculitis
¡E Management of Kawasaki disease

Fibromyalgia
¡E Advances in the treatment of fibromyalgia

Scleroderma
¡E Scleroderma lung disease
¡E Pulmonary hypertension in scleroderma
¡E Management of gastrointestional manifestations in scleroderma

Orthopedics
¡E The bone and joint decade 2010 and beyond ¡V the impact on translational research in
musculoskeletal disorders
¡E Orthopedic management of RA
¡E Orthopedic management of AS

Imaging in Rheumatology
¡E Usefulness of modern USG in the assessment and treatment of RA
¡E Application of USG in spondyloarthropathy
¡E The role of positron-emission tomography in rheumatology
¡E Common algorithms for reading hand, large joint and spine X-rays
¡E Utility of MRI in patients with back pain
¡E Interpretation of DEXA results

Osteoarthritis
¡E A comparison of modern OA guideline
¡E Health related quality of life in OA

Psoriatic Arthritis (PSA)
¡E Targeted therapies in PSA and future directions
¡E Outcome measures in PSA
¡E Subclinical atherosclerosis in PSA

Osteoporosis
¡E What is the risk of osteoporosis and fracture associated with different inflammatory
musculoskeletal conditions ¡V the epidemiological data
¡E How to prevent and treat glucocorticoid-induced osteoporosis
¡E Guidelines for the monitoring of bone turnover, bone mineral density and treatment in
postmenopausal osteoporosis

Inflammatory Myopathies
¡E An update on the assessment and treatment of inflammatory myopathies
¡E Novel autoantibodies and their relationship with the pathogenesis of inflammatory
myopathies
¡E Management of juvenile dermatomyositis

Crystal Arthropathies
¡E Mechanisms of monosodium urate-mediated inflammatory response
¡E Management of calcium pyrophosphate dihydrate deposition disease
¡E Gout and metabolic syndrome

Sjogren Syndrome
¡E Sjogren syndrome: current developments from a rheumatologist's point of view
¡E Diagnosis of sjogren syndrome: lessons from the SICCA Project

Antiphospholipid Syndrome
¡E Antiphospholipid antibodies: from bench to bedside
¡E Antiphospholipid syndrome dilemmas still to be solved: 2010 status

Pediatrics
¡E Update on use of biologics in juvenile idiopathic arthritis
¡E Pediatric lupus: from genetics to clinical management
¡E Inflammatory myopathies in children
¡E Kawasaki disease - what next if intravenous immunoglobulin fails

Allied Health
¡E Exercises for people with OA
¡E Life style re-design for people with RA
¡E Pain Management ¡V alternatives to pharmacological approach

Basic Science
Dysregulation of Immune System in Autoimmunity
¡E Toll like receptor in autoimmunity
¡E Dendritic cells in rheumatic diseases
¡E B cell in rheumatic diseases

Pathogenesis of Systemic Lupus Erythematosus
¡E Novel cytokines in SLE
¡E A review of genetics of SLE in Asia
¡E T/B lymphocytic biomarkers in SLE patients

Pathogenesis of other Rheumatic Diseases
¡E Immune dysregulation and therapeutic targets in scleroderma
¡E Immunopathogenesis of AS: role of T cells
¡E Pathogenesis of adult onset still disease

Regulatory T cells in Rheumatic Diseases
¡E Regulatory T cell and Th17
¡E Inducing regulatory cells to control autoimmunity - the role of Treg cells

Cytokines and Chemokines in Rheumatic Diseases
¡E Novel cytokines in inflammatory diseases
¡E Cytokines and disease activity in SLE
¡E Chemokines in arthritis

Mesenchymal Stem Cell
¡E Mesenchymal stem cell control of B cell
¡E Mesenchymal stem cell in SLE
¡E Chondrogenesis from mesenchymal stem cells

Genetics of Rheumatic Diseases
¡E Genetics in SLE
¡E Genetics of RA
¡E Genetics of AS

Pathogenesis of Neuropsychiatric Lupus
¡E Pathogenesis of neuropsychiatric lupus
¡E Autoantibody profile in neuropsychiatric lupus
¡E The story of the central nervous system involvement in SLE

Pathogenesis of Rheumatoid Arthritis
¡E The role of Th1 and Th17 in joint destruction
¡E Placenta growth factor in rheumatoid inflammation.
¡E Clinical development and trials of dendritic cell therapy for RA

Epigenetics in Rheumatic Diseases
¡E Epigenetic targets in the pathogenesis of RA
¡E The inhibitory effect of miRNA in RA
¡E MicroRNAs and lupus autoimmunity

Animal Model of Rheumatic Diseases
¡E Murine model of inflammatory arthritis
¡E Pathogenesis of lupus nephritis
¡E Th1/Th17 in inflammatory arthritis

Osteoimmunology
¡E Osteoimmunology in rheumatic diseases
¡E Regulation of osteoclastogenesis by cytokine
¡E Stem cell mobilization by osteoclast

Highlighted Symposia
¡E COPCORD Symposium
¡E EULAR Symposium on Early RA
¡E Gout Sympoisum

Education Series
¡E Workshops for young investigators in rheumatology:
          - How to conduct a successful clinical research
          - Overcome hurdles in preparing a manuscript: authors perspective
          - Overcome hurdles in preparing a manuscript: editors perspective
¡E Rheumatology pearls - case presentation